Navigation Links
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
Date:9/7/2010

uthority of any of our drug candidates in a timely manner, if at all, will severely undermine our business and results of operations by reducing our potential marketable products and our ability to generate corresponding product revenues.  The statements in this release are valid only as of the date hereof and we disclaim any obligation to update this information.Investor Contact: Marcy NanusThe Trout Group, LLCTelephone: 646-378-2927Email: mnanus@troutgroup.com
'/>"/>
SOURCE Protalix BioTherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Protalix BioTherapeutics to Dual List on Tel Aviv Stock Exchange
2. Protalix Announces Successful GMP Manufacturing Audit by Israels Ministry of Health
3. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
4. Talecris Biotherapeutics Announces Premerger HSR Filing
5. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
6. Northwest Biotherapeutics Raises Funding and Proceeds With Balance Sheet Restructuring
7. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
8. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
9. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
10. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
11. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Australian prostate cancer technology company ... science prize recognising ,outstanding, science that uses its patented ... launch a novel prostate cancer diagnostic test known as ... consortium taking out the peer-reviewed Australian Museum Eureka Science ... This prize is awarded for ground breaking ...
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... will improve efficiency of their entire waste to energy process and continue to ... Gets a Major Upgrade , Temarry’s Waste to Energy process has been operating ...
(Date:9/1/2015)... ... September 02, 2015 , ... Spirax Sarco , the leader in ... site Spirax Sarco Anytime. This platform, offering unique online ordering capabilities, is only ... order? Log on to Spirax Sarco Anytime and within minutes you can be ...
Breaking Biology Technology:Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Spirax Sarco Announces New Features to Anytime Platform 2
... SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The ... uncertainty is part of many,businesses and industries. It turns out ... downturn, because illness doesn,t take a,vacation. , ... the pharmaceutical,giant Johnson & Johnson inaugurated an R&D center in ...
... , INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. ... the fourth quarter ended December 31, 2009 of approximately $57 ... of 2008. Included in fourth quarter 2008 results was the ... Also included in fourth quarter 2008 results was a ...
... 1 Harvest Technologies Corp. ( www.harvesttech.com ) announced ... conducted at Sri Ramachandra Medical Center in Chennai, India ... non-reconstructable Critical Limb Ischemia (CLI). Sri Ramachandra Medical Center ... India and one of the largest private healthcare facilities ...
Cached Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
(Date:8/31/2015)... 31, 2015 Growing need for ... government digitization projects to drive India ... TechSci Research report, " India Biometrics Market Forecast & Opportunities, ... is projected to grow at a CAGR of over 35% ... on account of extensive use of biometric technology in the ...
(Date:8/24/2015)... TOWN, South Africa , August 24, 2015 ... Germany ,s largest biometrics manufacturer DERMALOG and ... with the "2015 African Biometrics Company of the Year ... in Nigeria .   -Cross ... and http://www.presseportal.de/nr/8896 - On Thursday evening, ...
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... Early-stage breast cancer that has not yet invaded the ... tumor one step closer to metastasis, report researchers at the ... in the Dec. 30 issue of the Journal of Cell ... wander off along milk ducts and seed new tumors within ...
... loss of deep-sea species poses a severe threat to the ... online on December 27th and in the January 8th issue ... global-scale study, the researchers found some of the first evidence ... the rate of critical ecosystem processes, increases exponentially with the ...
... rearrangements, resulting in variations in the numbers of copies ... DNA during cell division stalls and then switches to ... of Medicine in Houston in a report that appears ... is called replication Fork Stalling and Template Switching, said ...
Cached Biology News:Breast cancer cells have to learn to walk before they can run 2Deep-sea species' loss could lead to oceans' collapse, study suggests 2Copy number variation may stem from replication misstep 2Copy number variation may stem from replication misstep 3
DAP12 Market Segment: Protein Kinases...
G-protein coupled purinergic receptor P2Y8...
Phospho-FAK (Tyr576/577) Antibody...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: